Amdocs Net Receivables from 2010 to 2026

AOS Stock  EUR 60.30  2.04  3.27%   
Amdocs' Net Receivables is decreasing over the last several years with slightly volatile swings. Net Receivables is estimated to finish at about 617 M this year. During the period from 2010 to 2026 Amdocs Limited Net Receivables regressed destribution of quarterly values had coefficient of variationof  18.53 and r-value of (0.31). View All Fundamentals
 
Net Receivables  
First Reported
2017-03-31
Previous Quarter
589.8 M
Current Value
962.8 M
Quarterly Volatility
127.6 M
 
Covid
 
Interest Hikes
Check Amdocs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amdocs' main balance sheet or income statement drivers, such as Interest Expense of 51.2 M, Selling General Administrative of 542.7 M or Total Revenue of 4.6 B, as well as many indicators such as . Amdocs financial statements analysis is a perfect complement when working with Amdocs Valuation or Volatility modules.
  
This module can also supplement various Amdocs Technical models . Check out the analysis of Amdocs Correlation against competitors.
For more detail on how to invest in Amdocs Stock please use our How to Invest in Amdocs guide.
The Net Receivables trend for Amdocs Limited offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Amdocs is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Amdocs' Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Amdocs Limited over the last few years. It is Amdocs' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amdocs' overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Amdocs Net Receivables Regression Statistics

Arithmetic Mean738,214,920
Geometric Mean727,303,843
Coefficient Of Variation18.53
Mean Deviation95,054,744
Median715,837,000
Standard Deviation136,762,814
Sample Variance18704.1T
Range510.2M
R-Value(0.31)
Mean Square Error18013.1T
R-Squared0.1
Significance0.22
Slope(8,440,830)
Total Sum of Squares299265.1T

Amdocs Net Receivables History

2026617 M
2025530.8 M
2024589.8 M
2023665.7 M
2022733 M
2021789.6 M
2020704.5 M

About Amdocs Financial Statements

Amdocs stakeholders use historical fundamental indicators, such as Amdocs' Net Receivables, to determine how well the company is positioned to perform in the future. Although Amdocs investors may analyze each financial statement separately, they are all interrelated. For example, changes in Amdocs' assets and liabilities are reflected in the revenues and expenses on Amdocs' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Amdocs Limited. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Receivables530.8 M617 M

Currently Active Assets on Macroaxis

Other Information on Investing in Amdocs Stock

Amdocs financial ratios help investors to determine whether Amdocs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amdocs with respect to the benefits of owning Amdocs security.